Purpose: Longitudinal studies in rat models of retinopathy of prematurity (ROP) have demonstrated that abnormalities of retinal vasculature and function change hand-in-hand. In the developing retina, vascular and neural structures are under cooperative molecular control. In this study of rats with oxygen-induced retinopathy (OIR) models of ROP, mRNA expression of vascular endothelial growth factor (VEGF), semaphorin (Sema), and their neuropilin receptor (NRP) were examined during the course of retinopathy to evaluate their roles in the observed neurovascular congruency. Methods: Oxygen exposures designed to induce retinopathy were delivered to Sprague-Dawley rat pups (n=36) from postnatal day (P) 0 to P14 or from P7 to P14. Room-air-reared ...
To study the effects of vascular endothelial growth factor (VEGF) on endothelial nitric oxide synthe...
To study NAD(P)H oxidase-dependent outcomes after oxygen stresses that are similar to those experien...
Clifford B Kim,1,2 Patricia A D’Amore,2–4 Kip M Connor1,2 1Angiogenesis Laboratory, Mass...
To determine the effect of oxygen fluctuations on the expression of vascular endothelial growth fact...
Objective: To determine the effects of oxygen fluctuations on pigment epithelial-derived factor (PED...
© 2012 Dr. Kate Margaret HatzopoulosRetinopathy of prematurity (ROP) is characterised by retinal neo...
PURPOSE: Retinopathy of prematurity (ROP) is a retinal disease in which prematurity and high oxygen ...
Vascular endothelial growth factor (VEGF) A is implicated in aberrant angiogenesis and intravitreous...
To investigate whether oxygen stresses experienced in retinopathy of prematurity (ROP) would trigger...
Oxygen-induced retinopathy (OIR) upregulates Müller cell vascular endothelial growth factor A (VEGFA...
To describe the effects of oxygen fluctuations and supplemental oxygen (SO), stresses relevant to pr...
Purpose—Fluctuations in oxygen are associated with the development of severe retinopathy of prematur...
Vascular endothelial growth factor (VEGF) A is implicated in aberrant angiogenesis and intravitreous...
PURPOSE: To develop oxygen-induced retinopathy in the mouse with reproducible and quantifiable proli...
Background: We aimed to identify global blood and retinal gene expression patterns in murine oxygen-...
To study the effects of vascular endothelial growth factor (VEGF) on endothelial nitric oxide synthe...
To study NAD(P)H oxidase-dependent outcomes after oxygen stresses that are similar to those experien...
Clifford B Kim,1,2 Patricia A D’Amore,2–4 Kip M Connor1,2 1Angiogenesis Laboratory, Mass...
To determine the effect of oxygen fluctuations on the expression of vascular endothelial growth fact...
Objective: To determine the effects of oxygen fluctuations on pigment epithelial-derived factor (PED...
© 2012 Dr. Kate Margaret HatzopoulosRetinopathy of prematurity (ROP) is characterised by retinal neo...
PURPOSE: Retinopathy of prematurity (ROP) is a retinal disease in which prematurity and high oxygen ...
Vascular endothelial growth factor (VEGF) A is implicated in aberrant angiogenesis and intravitreous...
To investigate whether oxygen stresses experienced in retinopathy of prematurity (ROP) would trigger...
Oxygen-induced retinopathy (OIR) upregulates Müller cell vascular endothelial growth factor A (VEGFA...
To describe the effects of oxygen fluctuations and supplemental oxygen (SO), stresses relevant to pr...
Purpose—Fluctuations in oxygen are associated with the development of severe retinopathy of prematur...
Vascular endothelial growth factor (VEGF) A is implicated in aberrant angiogenesis and intravitreous...
PURPOSE: To develop oxygen-induced retinopathy in the mouse with reproducible and quantifiable proli...
Background: We aimed to identify global blood and retinal gene expression patterns in murine oxygen-...
To study the effects of vascular endothelial growth factor (VEGF) on endothelial nitric oxide synthe...
To study NAD(P)H oxidase-dependent outcomes after oxygen stresses that are similar to those experien...
Clifford B Kim,1,2 Patricia A D’Amore,2–4 Kip M Connor1,2 1Angiogenesis Laboratory, Mass...